Jump to:
- Does Wegovy Cause Ovarian Cysts? What the Evidence Shows
- How Wegovy May Affect Hormones, Periods and PCOS
- Ovarian Cysts vs Wegovy Side Effects: What Symptoms Should You Look For?
- Ovarian Cysts: Causes, Symptoms and Risk Factors
- When to Seek Help for Pelvic Symptoms on WegovyΒ
- Conclusion: Wegovy and Ovarian Cysts
Starting Wegovy can bring noticeable changes beyond the number on the scales. If pelvic discomfort, altered periods or unfamiliar reproductive symptoms appear during treatment, it is natural to wonder whether the Wegovy injection could be affecting the ovaries or contributing to cyst formation.
So far, available safety information has not identified ovarian cysts as an established concern with Wegovy, although reproductive symptoms during treatment may still need individual assessment. However, reproductive symptoms can have many causes, which makes context important. This guide explores what current evidence tells us, where uncertainty remains, and which symptoms should prompt medical assessment.
Wegovy
- β ~16.9% average body weight loss
- β Boosts metabolic & cardiovascular health
- β Proven, long-established safety profile
- β Weekly injection, easy to use
Key Facts About Wegovy and Ovarian Cysts
- Research has not established ovarian cysts as a side effect of Wegovy.
- Current evidence does not show that Wegovy causes ovarian cysts.
- Ovarian cysts are not recognised among established Wegovy side effects.
- Weight loss may influence periods, ovulation and reproductive hormones.
- PCOS-related follicles are different from typical ovarian cysts.
- Bloating and abdominal discomfort can overlap with Wegovy-related digestive effects.
- Persistent, unusual or severe pelvic symptoms should be medically assessed.
Does Wegovy Cause Ovarian Cysts? What the Evidence Shows
Current evidence does not show that Wegovy causes ovarian cysts. Ovarian cysts are not recognised among established Wegovy injection side effects, and no causal link with semaglutide has been confirmed.
Clinical and Regulatory Evidence
Clinical trials and safety information from the MHRA and EMA do not list ovarian cysts as a recognised adverse effect of Wegovy. This regulatory evidence helps distinguish an event occurring during treatment from an adverse effect proven to result from the medicine.
Weight Loss and Hormonal Changes
Significant weight loss can affect oestrogen levels, ovulation and menstrual regularity. These changes may sometimes cause reproductive symptoms that create concern about Wegovy and ovarian cysts, but they are not evidence of direct cyst formation.
PCOS and Ovarian Function
In people with PCOS, weight loss and improved insulin sensitivity may support more regular ovulation and menstrual cycles. PCOS is also different from ordinary ovarian cysts, as the small follicles associated with the condition are not the same as functional cysts.
Reports Versus Proven Side Effects
Some people may discover ovarian cysts while taking GLP-1 medicines, but correlation does not establish causation. Functional ovarian cysts are common and often occur independently of medication.
Persistent pelvic pain, unusual bleeding or other reproductive changes should therefore be assessed rather than automatically attributed to the weight loss injection Wegovy.
How Wegovy May Affect Hormones, Periods and PCOS
Wegovy does not directly regulate reproductive hormones, but the weight loss and metabolic changes associated with treatment can influence menstrual patterns and ovarian function. Changes in body fat, insulin sensitivity and energy balance may affect the hormonal signals involved in ovulation, particularly when weight loss is substantial.
Period and Hormonal Changes
Body fat plays a role in oestrogen metabolism, so meaningful weight loss can sometimes coincide with changes in cycle timing, flow or regularity. These shifts may be temporary and do not mean the Wegovy injection is causing ovarian cysts.
Wegovy and PCOS
PCOS is commonly associated with insulin resistance, higher androgen levels and irregular ovulation. GLP-1 medicines can support weight loss and metabolic improvement, and studies of semaglutide have reported improvements in insulin resistance and menstrual regularity in some people with PCOS. However, the evidence remains limited and results vary between studies.
Improved insulin sensitivity may also reduce some of the metabolic drivers linked with excess androgen activity, which could help explain why periods or ovulation become more regular during weight loss. This is different from saying Wegovy directly treats ovarian cysts.
Wegovy Is Not an Approved PCOS Treatment
Wegovy is licensed for weight management, not specifically for PCOS or ovarian cysts. Although improving weight and metabolic health may positively affect reproductive symptoms in some people with PCOS, it should not be viewed as a direct treatment for either condition.
These metabolic changes may therefore help explain why menstrual patterns or ovulation can shift during weight loss treatment.
Ovarian Cysts vs Wegovy Side Effects: What Symptoms Should You Look For?
Digestive symptoms during Wegovy treatment can sometimes overlap with symptoms associated with ovarian conditions. Looking at the location, pattern and accompanying symptoms can help distinguish between them.
| Symptom | Ovarian Cysts | Wegovy Side Effects |
| Pelvic pain or pressure | Dull ache, one-sided discomfort or pelvic pressure may occur | Not usually pelvic-specific |
| Abdominal pain | Possible, particularly with larger cysts | Stomach or abdominal discomfort is common |
| Bloating or fullness | May cause lower abdominal fullness or pressure | Bloating and gas can occur |
| Menstrual changes | Irregular periods or mid-cycle discomfort may occur | Not a typical direct side effect, although weight loss may influence cycles |
| Nausea or vomiting | Possible with rupture or ovarian torsion | Nausea and vomiting are common, especially during dose escalation |
| Diarrhoea or constipation | Constipation may occur from pelvic pressure; diarrhoea is less typical | Both are common |
| Urinary pressure | Larger cysts may increase the need to urinate | Not a typical Wegovy effect |
| Fatigue, headache or dizziness | Not characteristic cyst symptoms | Can occur with Wegovy |
| No symptoms | Many cysts are found incidentally on ultrasound | Some people experience few or no adverse effects |
Abdominal discomfort alone does not confirm an ovarian cyst. Persistent pelvic pressure, one-sided pain, menstrual changes or pain during intercourse deserve attention. Sudden or rapidly worsening pelvic symptoms may require prompt medical assessment. For less urgent concerns, an online consultation can help clarify symptoms and appropriate next steps.
Ovarian Cysts: Causes, Symptoms and Risk Factors
Ovarian cysts are fluid-filled sacs that form on or within an ovary. Many develop naturally during the menstrual cycle and resolve without treatment, while others are linked with conditions such as endometriosis or hormonal disorders.
What Causes Ovarian Cysts?
Functional cysts are the most common. Follicular cysts form when an egg is not released, while corpus luteum cysts may develop after ovulation. Other types include endometriomas, dermoid cysts and cystadenomas. PCOS is different from having a typical ovarian cyst. It is a hormonal and metabolic condition often associated with multiple small immature follicles.
Ovarian Cyst Symptoms
Some cysts cause no symptoms and are only discovered during an ultrasound. Possible ovarian cysts symptoms include one-sided pelvic pain, bloating, pain during intercourse, menstrual changes, urinary pressure and constipation.
Risk Factors and Complications
Risk factors include hormonal imbalance, previous ovarian cysts, endometriosis, pelvic infection and PCOS. These conditions can occur independently of Wegovy.
Most cysts are harmless, but complications such as cyst rupture or ovarian torsion can occasionally occur and may require urgent treatment. Ovarian cysts found after menopause also generally need closer evaluation.
What to Do if You Develop an Ovarian Cyst
If an ovarian cyst is found, treatment depends on its size, appearance, symptoms and whether you have reached menopause. Many simple cysts only need monitoring and a follow-up ultrasound, while persistent, large or symptomatic cysts may need specialist review.
If you are taking Wegovy, do not stop treatment solely because a cyst has been discovered unless your prescriber advises you to. Your clinician can determine whether monitoring, repeat imaging or specialist review is needed.
When to Seek Help for Pelvic Symptoms on Wegovy
Pelvic symptoms should not always be assumed to be related to Wegovy, especially if they are persistent, unusual or worsening.
Seek medical advice for:
- ongoing or unexplained pelvic pain
- new or significant menstrual changes
- pain during sex
- unusual vaginal bleeding
- symptoms that keep returning or become more severe
Seek urgent medical help for sudden severe pelvic or abdominal pain with vomiting, dizziness, fainting or weakness, as this may indicate ovarian torsion or a ruptured cyst. A clinician can assess your symptoms, review your treatment and arrange a pelvic ultrasound or other tests if needed.
Conclusion: Wegovy and Ovarian Cysts
The available evidence remains reassuring, while also showing why reproductive symptoms during weight loss treatment need to be considered in context. Hormonal changes, PCOS and naturally occurring ovarian cysts can each affect periods or pelvic symptoms independently.
If you develop persistent pelvic pain, menstrual changes or other unusual reproductive symptoms while using the Wegovy injection, it is important to have them assessed rather than assuming they are treatment-related. London Slimming Clinic can support you with clinically supervised weight loss treatment and guidance on whether new symptoms may require further medical assessment, monitoring or referral.
Mounjaro
- β ~22.5% average body weight loss
- β Significant weight reduction
- β Improves blood sugar levels
- β Clinically proven weight loss
Wegovy
- β ~16.9% average body weight loss
- β Boosts metabolic & cardiovascular health
- β Proven, long-established safety profile
- β Weekly injection, easy to use
FAQs About Wegovy and Ovarian Cysts
Most ovarian cysts do not affect fertility, especially functional cysts that resolve naturally. However, conditions linked with cysts, such as endometriosis, can sometimes make conception more difficult. If treatment is required, clinicians usually aim to preserve ovarian function wherever possible.
The direct effect of semaglutide on fertility is not fully established. Weight loss and improved metabolic health may influence ovulation, particularly in people with irregular cycles, but Wegovy is not a fertility treatment.
Wegovy should be stopped at least two months before a planned pregnancy because semaglutide remains in the body for several weeks. Speak with your prescriber before stopping or changing treatment.
Wegovy is not recommended during breastfeeding because there is insufficient evidence to confirm its safety for the baby. Treatment options and the appropriate time to restart semaglutide should be discussed with a healthcare professional.
Yes. A pelvic ultrasound can show the cystβs size, location and appearance. Depending on the findings, your clinician may recommend monitoring, a repeat scan or further investigation.
Many functional ovarian cysts disappear naturally within a few months and need no treatment. Larger, persistent, symptomatic or unusual-looking cysts may require additional monitoring or specialist assessment.
Most ovarian cysts are benign. The risk of malignancy is generally higher after menopause, so suspicious or persistent cysts may require further scans, blood tests or referral to a gynaecology specialist.
Yes. New cysts can develop after a previous cyst has resolved or been treated, particularly functional cysts linked with ovulation. Recurrent cysts may sometimes warrant investigation for underlying conditions such as endometriosis or hormonal disorders.
UK-based prescribers
GPhC registered pharmacy
UK-based pharmacy
Qualified clinical team
Confidential and discreet delivery